Foundation Medicine’s Breakthrough Personalized Cancer Care Relies on Thermo Scientific Nautilus LIMS

Foundation Medicine’s Breakthrough Personalized Cancer Care Relies on Thermo Scientific Nautilus LIMS

This article is brought to you by: 

Founded by world leaders in genome technology, cancer biology and medical oncology, Foundation Medicine is a cancer diagnostics company at the forefront of bringing comprehensive genomic analysis to routine cancer care. The Cambridge, Mass.-based company’s clinical laboratory services help physicians and their patients develop customized cancer treatment and therapy based on an individual tumor’s molecular subtype. Key to this process is Foundation Medicine’s Next-Generation Sequencing (NGS) platform, which extracts relevant genomic information from small amounts of cancer tissue.

Premium Access
To access this content please enter your details in the fields below. If you believe you have already done so for this, please resubmit your details in the next form down.
Already registered?
If you believe you have already registered please submit the email you originally entered.